Better monitoring of anti-rejection medicines after transplant
Part of Kidney & urinary clinical trials.
This study looks at how to better manage anti-rejection medicines (tacrolimus and mycophenolate) in children and teens who have had an organ transplant. It uses text messages to help monitor drug levels, which might make treatment easier and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have received an organ transplant and be at least 1 year old.
- You must be taking tacrolimus or mycophenolate (anti-rejection medicines).
- You must be willing to get text message reminders and have a phone that can send and receive texts and pictures.
- You must be able to understand and sign a consent form, and read and speak English.
- You cannot have an allergy to adhesive tapes (like bandage tape).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether continuing certain anti-rejection medicines while on dialysis can help lower the risk of your immune system becoming too sensitive to a future kidney transplant. It might help you stay eligible for another transplant later.
This trial tests a new approach to help teenagers and young adults keep their first kidney transplant working well. It looks at how to improve long-term success by carefully managing the immune system around the time of transplant.
This Phase 2 study looks at whether blood test “biomarkers” can guide safely changing anti-rejection medicines after an ABO-compatible kidney transplant. It may help some people reduce certain medicines while keeping the new kidney protected from rejection.
This trial tests a blood test that may help monitor kidney transplant health by detecting signs of rejection earlier. It aims to see if using this blood test can lead to better long-term outcomes for transplant recipients.
This study looks at how well tacrolimus, a medicine that prevents kidney rejection, works in people after a kidney transplant. By checking your immune system and your medicine levels, the goal is to find the best dose for each person to keep your new kidney healthy.
This study tests a new approach to managing anti-rejection medicines after a heart transplant. It uses special blood tests to see if your immune system is calm, so doctors can safely reduce the medicines and lower side effects.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.